Literature DB >> 26798715

Statistical Challenges in Identifying Risk Factors for Aortic Disease.

John A Rizzo, Jie Chen1, Hai Fang2, Bulat A Ziganshin, John A Elefteriades3.   

Abstract

Being largely asymptomatic, thoracic aortic aneurysms pose a challenge for the physician to identify and intervene in time to prevent death or a major complication. Knowing how to accurately analyze the available clinical data is vital to informing the proper management of these patients. This paper seeks to provide an overview of the statistical methods most commonly used to analyze clinical outcomes with a special focus on research related to aortic disease.

Entities:  

Keywords:  Aortic aneurysm; Clinical outcomes; Statistical methods

Year:  2014        PMID: 26798715      PMCID: PMC4682756          DOI: 10.12945/j.aorta.2014.14-019

Source DB:  PubMed          Journal:  Aorta (Stamford)        ISSN: 2325-4637


  10 in total

1.  The problem of overfitting.

Authors:  Douglas M Hawkins
Journal:  J Chem Inf Comput Sci       Date:  2004 Jan-Feb

2.  Procedures for estimating growth rates in thoracic aortic aneurysms.

Authors:  J A Rizzo; M A Coady; J A Elefteriades
Journal:  J Clin Epidemiol       Date:  1998-09       Impact factor: 6.437

3.  Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications.

Authors:  M A Coady; J A Rizzo; G L Hammond; G S Kopf; J A Elefteriades
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

4.  Familial thoracic aortic aneurysms and dissections--incidence, modes of inheritance, and phenotypic patterns.

Authors:  Gonzalo Albornoz; Michael A Coady; Michele Roberts; Ryan R Davies; Maryann Tranquilli; John A Rizzo; John A Elefteriades
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

5.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

Review 6.  Thoracic aortic aneurysm clinically pertinent controversies and uncertainties.

Authors:  John A Elefteriades; Emily A Farkas
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

7.  Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve.

Authors:  Ryan R Davies; Ryan K Kaple; Divakar Mandapati; Amy Gallo; Donald M Botta; John A Elefteriades; Michael A Coady
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

8.  'Bovine' aortic arch - a marker for thoracic aortic disease.

Authors:  Matthew Hornick; Remo Moomiaie; Hamid Mojibian; Bulat Ziganshin; Zakaria Almuwaqqat; Esther S Lee; John A Rizzo; Maryann Tranquilli; John A Elefteriades
Journal:  Cardiology       Date:  2012-09-28       Impact factor: 1.869

9.  Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.

Authors:  M McClellan; B J McNeil; J P Newhouse
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

10.  Concurrent intracranial and thoracic aortic aneurysms.

Authors:  Gregory A Kuzmik; Marina Feldman; Maryann Tranquilli; John A Rizzo; Michele Johnson; John A Elefteriades
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778

  10 in total
  3 in total

Review 1.  Dissecting the Dissection: Towards More Comprehensive Decision-Making Methodology for Thoracic Aortic Disease.

Authors:  Hisham M F Sherif
Journal:  Aorta (Stamford)       Date:  2015-06-01

2.  Open Replacement of the Thoracoabdominal Aorta: Short- and Long-term Outcomes at a Single Institution.

Authors:  Davide Carino; Young Erben; Mohammad A Zafar; Mrinal Singh; Adam J Brownstein; Maryann Tranquilli; John Rizzo; Bulat A Ziganshin; John A Elefteriades
Journal:  Int J Angiol       Date:  2018-05-23

3.  Simple Renal Cysts as Markers of Thoracic Aortic Disease.

Authors:  Bulat A Ziganshin; Panagiotis Theodoropoulos; Mohammad N Salloum; Khaled J Zaza; Maryann Tranquilli; Hamid R Mojibian; Neera K Dahl; Hai Fang; John A Rizzo; John A Elefteriades
Journal:  J Am Heart Assoc       Date:  2016-01-08       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.